Mylan N.V. (NASDAQ:MYL) saw its share price trade relatively negative in the recent trading session. The share price was last updated to $44.88 with a loss of -0.5 points or -1.1%. The net money flow was $7.21 million and the up/down ratio was 1.26. Approximately $35.24 million was the inflow in upticks and $28.02 million was the outflow in downticks. On a weekly measure, the shares have seen a price change of -0.29%.The shares witnessed a block transaction with a net money flow of $5.89 million. The total money in uptick was $5.89 million and in downtick was $0 million with the up/down ratio reaching 0.
The stock has recorded a 20-day Moving Average of 0.94% and the 50-Day Moving Average is 2.16%. The company shares have dropped 36.1% in the past 52 Weeks. On July 6, 2015 The shares registered one year high of $73.9 and one year low was seen on October 22, 2015 at $37.59. The 50-day moving average is $42.97 and the 200 day moving average is recorded at $47.34. S&P 500 has rallied 1.93% during the last 52-weeks.
Mylan N.V. (NASDAQ:MYL): The stock opened at $45.56 on Tuesday but the bulls could not build on the opening and the stock topped out at $45.79 for the day. The stock traded down to $44.06 during the day, due to lack of any buying support eventually closed down at $44.88 with a loss of -1.10% for the day. The stock had closed at $45.38 on the previous day. The total traded volume was 5,221,269 shares.
Currently the company Insiders own 0.71% of Mylan N.V. shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -13.09% . Institutional Investors own 66.47% of Mylan N.V. shares. During last six month period, the net percent change held by insiders has seen a change of -11.04%. On the companys insider trading activities, Maroon Joseph C Md, director of Mylan N.V., executed a transaction worth $75,067 on June 3, 2016. A total of 1,670 shares were purchased at an average price of $44.95. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Mylan N.V., formerly Mylan Inc., is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty. The Companys generic pharmaceutical business is conducted primarily in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA); and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its specialty pharmaceutical business is conducted by Mylan Specialty L.P. (Mylan Specialty). The Companys API business is conducted through Mylan Laboratories Limited (Mylan India), which is included within the Asia Pacific region in its Generics Segment. Mylan provides products to customers in approximately 140 countries and territories.